NK Cell-Based Cancer Immunotherapies: Current Progress, Challenges and Emerging Opportunities

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Natural killer (NK) cells are key innate immune cells with significant antitumor functions.
• Current immunotherapies aim to enhance NK cell activity, but face challenges.
• NK cell-derived exosomes (NDEs) present a safe and modifiable alternative for cancer treatment.

Purpose of the Study:

• To review the antitumor potential of NK cells and NK cell-based immunotherapies.
• To explore challenges and opportunities in NK cell transplantation and CAR NK cell therapy.
• To highlight the potential of NDEs in cancer immunotherapy.

Main Methods:

• Literature review of NK cell-based cancer therapies.
• Analysis of NK cell-derived exosomes (NDEs) as therapeutic agents.
• Exploration of combination strategies for enhanced cancer immunotherapy.

Main Results:

• NK cells are vital for innate immunity and cancer therapy.
• NDEs offer immune safety and modifiability for enhanced therapeutic efficacy.
• NDEs can reprogram the tumor microenvironment and improve immunotherapy outcomes.

Conclusions:

• NK cell-based immunotherapies, including NDEs, hold significant promise for cancer treatment.
• NDEs can be utilized alone or in combination therapies to improve efficacy and reduce side effects.
• Further clinical research into NDEs is warranted to expedite cancer immunotherapy.